Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Brain Injury, 20(1), 7583
J Biol Chem 235:24852491
Inhibitors of cyclin-dependent kinase 4 (CDK4), a serine-/threonine kinase controlling cell survival and death, reduce stress-induced eryptosis [158]
93,94,95,96 Advancements in carrier technology and nucleic acid modification techniques have led to significant progress in overcoming these challenges, as exemplified by the first siRNA drug, patisiran (Onpattro), which has been approved for treating hereditary transthyretin-mediated amyloidosis by degrading mRNA encoding transthyretin (TTR)
US$ 21.42
US$ 22.36
US$ 24.10
US$ 23.15
US$ 29.43
